Predicting the risk of chemotherapy toxicity in older patients: The chemotherapy risk assessment scale for high-age patients (CRASH) score

Cancer

Volumn 118, Issue 13, 2012, Pages 3377-3386

  Extermann, Martine ^a   Boler, Ivette ^a   Reich, Richard R ^a,b   Lyman, Gary H ^c   Brown, Richard H ^d   Defelice, Joseph ^e   Levine, Richard M ^f   Lubiner, Eric T ^g   Reyes, Pablo ^h   Schreiber III, Frederic J ⁱ   Balducci, Lodovico ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA SARASOTA MANATEE   (United States)

^c DUKE UNIVERSITY   (United States)

^d SARASOTA MEMORIAL HOSPITAL   (United States)

^e Morton Plant Hospital   (United States)

^f Space Coast Medical Associates ^*  (United States)

^g Fawcet Memorial Hospital   (United States)

^h Leesburg Regional Hospital   (United States)

ⁱ Watson Clinic   (United States)

Author keywords

Chemotherapy; Chemotherapy Risk Assessment Scale for High Age Patients (CRASH) score; Chemotherapy side effects; Common Toxicity Criteria for Adverse Events version 3.0; Elderly; MAX 2; Predictive score

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; CAPECITABINE; CARBOPLATIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; GROWTH FACTOR; HEMOGLOBIN; IRINOTECAN; LACTATE DEHYDROGENASE; METHOTREXATE; OXALIPLATIN; PACLITAXEL; PEMETREXED; PREDNISONE; TOPOTECAN; VINCRISTINE;

ADVERSE DRUG REACTION; AGED; ANALYTICAL PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS; CONTROLLED STUDY; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG WITHDRAWAL; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE; FEMALE; HEALTH STATUS; HODGKIN DISEASE; HUMAN; INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCORE; INTERMETHOD COMPARISON; INTERNAL VALIDITY; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG NON SMALL CELL CANCER; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MINI MENTAL STATUS SCORE; MINI NUTRITIONAL ASSESSMENT SCORE; MULTICENTER STUDY; NEUTROPENIA; NONHEMATOLOGIC TOXICITY; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK ASSESSMENT SCALE FOR HIGH AGE PATIENTS SCORE; SCORING SYSTEM; SELF EVALUATION; STATISTICAL MODEL; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84862575323     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26646     Document Type: Article

References (36)

1. Copeland GP, Jones D, Walters M,. POSSUM: a scoring system for surgical audit. Br J Surg. 1991; 78: 355-360.
2. Extermann M, Bonetti M, Sledge GW, O'Dwyer PJ, Bonomi P, Benson AB 3rd., MAX2âa convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer. 2004; 40: 1193-1198. (Pubitemid 38526338)
3. Extermann M, Chen H, Cantor AB, et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer. 2002; 38: 1466-1473. (Pubitemid 34756399)
4. Dees EC, O'Reilly S, Goodman SN, et al. A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest. 2000; 18: 521-529. (Pubitemid 30485668)
5. Hurria A, Brogan K, Panageas KS, et al. Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Drugs Aging. 2005; 22: 709-715. (Pubitemid 41138982)
6. Crawford J, Dale DC, Kuderer NM, et al. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J Natl Compr Canc Netw. 2008; 6: 109-118. (Pubitemid 351340522)
7. Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M,. Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy. Leuk Lymphoma. 2003; 44: 2069-2076. (Pubitemid 37369646)
8. Intragumtornchai T, Sutheesophon J, Sutcharitchan P, Swasdikul D,. A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma. Leuk Lymphoma. 2000; 37: 351-360. (Pubitemid 30162545)
9. Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol. 2005; 16: 1795-1800. (Pubitemid 41631242)
10. Bachelot T, Ray-Coquard I, Catimel G, et al. Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials. Ann Oncol. 2000; 11: 151-156. (Pubitemid 30148727)
11. Hurria A, Hurria A, Brogan K, et al. Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer. Drugs Aging. 2005; 22: 785-791.
12. Ray-Coquard I, Le Cesne A, Rubio MT, et al. Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group. J Clin Oncol. 1999; 17: 2840-2846. (Pubitemid 29415242)
13. Martell RE, Peterson BL, Cohen HJ, et al. Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB coordinated intergroup study. Cancer Chemother Pharmacol. 2002; 50: 37-45. (Pubitemid 34743994)
14. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992; 41: 237-248.
15. Gronberg BH, Sundstrom S, Kaasa S, et al. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010; 46: 2225-2234.
16. Zauderer M, Patil S, Hurria A,. Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer. Breast Cancer Res Treatment. 2009; 117: 205-210.
17. Ray-Coquard I, Ghesquiere H, Bachelot T, et al. Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas. Br J Cancer. 2001; 85: 816-822. (Pubitemid 33010546)
18. Ray-Coquard I, Borg C, Bachelot T, et al. Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy. Br J Cancer. 2003; 88: 181-186. (Pubitemid 36255833)
19. Lichtman SM, Wildiers H, Launay-Vacher V, Steer C, Chatelut E, Aapro M,. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer. 2007; 43: 14-34. (Pubitemid 46070218)
20. Zubrod CS, Frei E III, Brindley C, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960; 11: 7-33.
21. Lawton MP,. Scales to measure competence in everyday activities. Psychopharmacol Bull. 1988; 24: 609-614. (Pubitemid 19054365)
22. Guigoz Y, Vellas B, Garry PJ,. Mini Nutritional Assessment: a practical assessment tool for grading nutritional state of elderly patients. In:, Vellas BJ, Guigoz Y, Garry PJ, Albarede JL, eds. Facts Research and Intervention in Geriatrics. 3rd ed. New York: Serdi Publishing Company; 1997: 15-60.
23. Folstein MF, Folstein SE, McHugh PR,. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189-198.
24. Sheikh J, Yesavage JA,. Geriatric Depression Scale (GDS). Recent evidence and development of a shorter version. Clin Gerontol. 1986; 5 (1/2): 165-171.
25. Hosmer D, Lemeshow S,. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, Inc.; 2000.
26. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD,. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making. 2001; 21: 45-56. (Pubitemid 32245030)
27. Extermann M, Boler I, Brown RH, et al. Comparison of older patients receiving chemotherapy in the community versus an academic cancer center [abstract]. Crit Rev Oncol Hematol. 2009; 72 (suppl 1): S56.
28. Popa M, Wallace K, Brunello A, Extermann M,. The impact of polypharmacy on toxicity from chemotherapy in elderly patients: focus on cytochrome P-450 inhibition and protein binding effects [abstract]. J Clin Oncol. 2008; 26 (15S). Abstract 9505.
29. Chen H, Cantor A, Meyer J, et al. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer. 2003; 97: 1107-1114. (Pubitemid 36173165)
30. O'Leary CA, Extermann M,. Chemotherapy dose adjustment after severe toxicity in older cancer patients [abstract]. J Clin Oncol. 2008; 26 (May 20 suppl). Abstract 9627.
31. Meyers CA, Albitar M, Estey E,. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer. 2005; 104: 788-793. (Pubitemid 41113679)
32. Hurria A, Rosen C, Hudis C, et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc. 2006; 54: 925-931. (Pubitemid 43847029)
33. Chae CU, Lee RT, Rifai N, Ridker PM,. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001; 38: 399-403. (Pubitemid 34225673)
34. Vellas B, Guigoz Y, Baumgartner M, Garry PJ, Lauque S, Albarede JL,. Relationships between nutritional markers and the Mini-Nutritional Assessment in 155 older persons. J Am Geriatr Soc. 2000; 48: 1300-1309.
35. Sweeney CJ, Zhu J, Sandler AB, et al. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a phase II trial in patients with metastatic nonsmall cell lung carcinoma. Cancer. 2001; 92: 2639-2647. (Pubitemid 33049448)
36. Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011; 29: 3457-3465.